For hazardous non-sterile compounding, the level of requirements needed (i.e., B or C) depends more on the risk(s) posed by the hazardous product than on the complexity of the preparation.
In addition to the requirements for non-sterile compounding, such as adequate space and sufficient lighting (guidance document, section 5.4), hazardous non-sterile preparations should be compounded in a separate, dedicated room. For example, compounding hazardous products containing carcinogenic drugs listed in NIOSH† Table 1, or those categorized by WHMIS‡ as a health hazard because they are very irritating to the respiratory tract, skin and/or mucous membranes, should take place in a Level C room. This means a physically separate, closed-off room with external venting through HEPA filtration, appropriate air exchange and negative pressure to avoid contaminating the environment and to further protect personnel. There should also be an appropriate containment device (C-PEC) for materials being compounded.
Because of the difficulty of removing hazardous product contamination, the surfaces of ceilings, walls, floors, fixtures, shelving, counters and cabinets in the non-sterile compounding area should be smooth, impermeable, free from cracks and crevices and made of non-shedding material.
If a separate area is not possible and non-hazardous non-sterile preparations must be compounded in the same room as hazardous non-sterile preparations, at an absolute minimum there should be policies and procedures in place to ensure that the area is meticulously cleaned to prevention any risk of cross-contamination.
If you intend on compounding both non-hazardous and hazardous non-sterile preparations, refer to the FAQ “Do we need two separate designated compounding areas for hazardous and non-hazardous non-sterile preparations?” for additional considerations.
†National Institute for Occupational Safety and Health.
‡Workplace Hazardous Materials Information System.
Refer to Sections 9.1, 9.1.1, 9.2.1, 9.2.2 and 9.3 of the NAPRA Guidance Document for Pharmacy Compounding of Non-Sterile Preparations. Note that where the guidance document uses the language of “should,” it may be acceptable to meet the required standard using other technologies, techniques, materials and procedures than those suggested only if they have been proven to be equivalent or superior to those described in the guidance document.